Constipation. Understanding Mechanisms and Management.

Clinics in Geriatric Medicine

Volumn 30, Issue 1, 2014, Pages 107-115

  Costilla, Vanessa C ^a   Foxx Orenstein, Amy E ^a  

^a MAYO CLINIC   (United States)

Author keywords

Anorectal manometry; Chronic constipation; Constipation testing; Dyssynergic defecation; Outlet dysfunction; Pelvic floor dysfunction; Slow transit constipation

Indexed keywords

BENZATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CHLORIDE CHANNEL STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; CLONIDINE; CYCLIC GMP; DOCUSATE SODIUM; FERROUS SULFATE; LACTULOSE; LAXATIVE; LINACLOTIDE; LUBIPROSTONE; MACROGOL; MINERAL OIL; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OSMOTIC AGENT; PRUCALOPRIDE; SENNA EXTRACT; SEROTONIN AGONIST; SODIUM DIHYDROGEN PHOSPHATE; SORBITOL; SUCRALFATE; TEGASEROD; UNINDEXED DRUG; VERAPAMIL;

ABDOMINAL CRAMP; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ANORECTAL PRESSURE; ASPIRATION PNEUMONIA; BLOATING; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; COLONOSCOPY; CONSTIPATION; DEFECATION DISORDER; DIARRHEA; DRUG ABSORPTION; DRUG METABOLISM; DRUG TOLERABILITY; FEEDBACK SYSTEM; FLATULENCE; HEADACHE; HIGH FIBER DIET; HUMAN; IRRITABLE COLON; KINESIOTHERAPY; LIFESTYLE MODIFICATION; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITY OF LIFE; REVIEW; SCINTIGRAPHY; SEDENTARY LIFESTYLE; SELF CARE; UNSPECIFIED SIDE EFFECT;

ANORECTAL MANOMETRY; CHRONIC CONSTIPATION; CONSTIPATION TESTING; DYSSYNERGIC DEFECATION; OUTLET DYSFUNCTION; PELVIC FLOOR DYSFUNCTION; SLOW TRANSIT CONSTIPATION;

CONSTIPATION; AGE FACTORS; BIOFEEDBACK, PSYCHOLOGY; DIETARY FIBER; DISEASE MANAGEMENT; FOOD HABITS; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; PREVALENCE; RISK FACTORS; SEDENTARY LIFESTYLE;

EID: 84888170276     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2013.10.001     Document Type: Review

References (21)

1. Bharucha A.E., Dorn S.D., Lembo A., et al. American Gastroenterological Association medical position statement on constipation. Gastroenterology 2013, 144(1):211-217.
2. Higgins P.D., Johanson J.F. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004, 99(4):750-759.
3. Dennison C., Prasad M., Lloyd A., et al. The health-related quality of life and economic burden of constipation. Pharmacoeconomics 2005, 23(5):461-476.
4. Longstreth G.F., Thompson W.G., Chey W.D., et al. Functional bowel disorders. Gastroenterology 2006, 130(5):1480-1491.
5. Foxx-Orenstein A.E., McNally M.A., Odunsi S.T. Update on constipation: one treatment does not fit all. Cleve Clin J Med 2008, 75(11):813-824.
6. Gallegos-Orozco J.F., Foxx-Orenstein A.E., Sterler S.M., et al. Chronic constipation in the elderly. Am J Gastroenterol 2012, 107(1):18-25. [quiz: 26].
7. Ness J., Hoth A., Barnett M.J., et al. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. Am J Geriatr Pharmacother 2006, 4(1):42-51.
8. Traube M., McCallum R.W. Calcium-channel blockers and the gastrointestinal tract. American College of Gastroenterology's Committee on FDA related matters. Am J Gastroenterol 1984, 79(11):892-896.
9. Rao S.S., Singh S. Clinical utility of colonic and anorectal manometry in chronic constipation. JClin Gastroenterol 2010, 44(9):597-609.
10. Diamant N.E., Kamm M.A., Wald A., et al. AGA technical review on anorectal testing techniques. Gastroenterology 1999, 116(3):735-760.
11. Saad R.J., Hasler W.L. Atechnical review and clinical assessment of the wireless motility capsule. Gastroenterol Hepatol (N Y) 2011, 7(12):795-804.
12. Fletcher J.G., Busse R.F., Riederer S.J., et al. Magnetic resonance imaging of anatomic and dynamic defects of the pelvic floor in defecatory disorders. Am J Gastroenterol 2003, 98(2):399-411.
13. Bharucha A.E., Pemberton J.H., Locke G.R., et al. Gastroenterological Association technical review on constipation. Gastroenterology 2013, 144(1):218-238.
14. Xing J.H., Soffer E.E. Adverse effects of laxatives. Dis Colon Rectum 2001, 44(8):1201-1209.
15. Ford A.C., Suares N.C. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut 2011, 60(2):209-218.
16. Lacy B.E., Levy L.C. Lubiprostone: a novel treatment for chronic constipation. Clin Interv Aging 2008, 3(2):357-364.
17. Lacy B.E., Chey W.D. Lubiprostone: chronic constipation and irritable bowel syndrome with constipation. Expert Opin Pharmacother 2009, 10(1):143-152.
18. Barish C.F., Drossman D., Johanson J.F., et al. Efficacy and safety of lubiprostone in patients with chronic constipation. Dig Dis Sci 2010, 55(4):1090-1097.
19. Harris L.A., Crowell M.D. Linaclotide, a new direction in the treatment of irritable bowel syndrome and chronic constipation. Curr Opin Mol Ther 2007, 9(4):403-410.
20. Johnston J.M., Kurtz C.B., Macdougall J.E., et al. Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation. Gastroenterology 2010, 139(6):1877-1886.e2.
21. Silos-Santiago I., Hannig G., Eutamene H., et al. Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation. Pain 2013, 154(9):1820-1830.